384 related articles for article (PubMed ID: 17338926)
21. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma?
Stewart DJ
Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025
[No Abstract] [Full Text] [Related]
23. Severe pulmonary arterial hypertension: a forme fruste of cancer?
Humbert M; Hoeper MM
Am J Respir Crit Care Med; 2008 Sep; 178(6):551-2. PubMed ID: 18755928
[No Abstract] [Full Text] [Related]
24. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of pulmonary arterial hypertension.
Rabinovitch M
J Clin Invest; 2008 Jul; 118(7):2372-9. PubMed ID: 18596905
[TBL] [Abstract][Full Text] [Related]
26. Hypertension: A new therapeutic strategy for PAH.
Carney EF
Nat Rev Nephrol; 2015 Aug; 11(8):445. PubMed ID: 26122732
[No Abstract] [Full Text] [Related]
27. Absence of the calcium-binding protein, S100A1, confers pulmonary hypertension in mice associated with endothelial dysfunction and apoptosis.
Teichert-Kuliszewska K; Tsoporis JN; Desjardins JF; Yin J; Wang L; Kuebler WM; Parker TG
Cardiovasc Res; 2015 Jan; 105(1):8-19. PubMed ID: 25395393
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary hypertension: pathology.
Dorfmüller P
Handb Exp Pharmacol; 2013; 218():59-75. PubMed ID: 24092336
[TBL] [Abstract][Full Text] [Related]
29. Pathology and Pathobiology of Pulmonary Hypertension.
Guignabert C; Dorfmüller P
Semin Respir Crit Care Med; 2017 Oct; 38(5):571-584. PubMed ID: 29032561
[No Abstract] [Full Text] [Related]
30. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
[TBL] [Abstract][Full Text] [Related]
31. Bone morphogenetic proteins protect pulmonary microvascular endothelial cells from apoptosis by upregulating α-B-crystallin.
Ciumas M; Eyries M; Poirier O; Maugenre S; Dierick F; Gambaryan N; Montagne K; Nadaud S; Soubrier F
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2577-84. PubMed ID: 24072698
[TBL] [Abstract][Full Text] [Related]
32. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
[TBL] [Abstract][Full Text] [Related]
33. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
[TBL] [Abstract][Full Text] [Related]
34. Pathobiology of pulmonary hypertension. Extracellular matrix.
Rabinovitch M
Clin Chest Med; 2001 Sep; 22(3):433-49, viii. PubMed ID: 11590839
[TBL] [Abstract][Full Text] [Related]
35. [Pulmonary hypertension in rheumatic diseases].
Lang IM; Bonderman D; Skoro-Sajer N; Klepetko W; Kneussl M
Z Rheumatol; 2003 Feb; 62(1):2-9. PubMed ID: 12624796
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary hypertension: from molecular pathophysiology to haemodynamic abnormalities].
Duong-Quy S; Rivière S; Bei Y; Duong-Ngo C; Le-Dong NN; Hua-Huy T; Dinh-Xuan AT
Rev Mal Respir; 2012 Oct; 29(8):956-70. PubMed ID: 23101638
[TBL] [Abstract][Full Text] [Related]
37. Pathologic assessment of vasculopathies in pulmonary hypertension.
Pietra GG; Capron F; Stewart S; Leone O; Humbert M; Robbins IM; Reid LM; Tuder RM
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):25S-32S. PubMed ID: 15194175
[TBL] [Abstract][Full Text] [Related]
38. [Primary pulmonary hypertension].
Otsuka F; Makino H
Nihon Rinsho; 2005 Oct; 63 Suppl 10():450-7. PubMed ID: 16279681
[No Abstract] [Full Text] [Related]
39. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.
Marecki JC; Cool CD; Parr JE; Beckey VE; Luciw PA; Tarantal AF; Carville A; Shannon RP; Cota-Gomez A; Tuder RM; Voelkel NF; Flores SC
Am J Respir Crit Care Med; 2006 Aug; 174(4):437-45. PubMed ID: 16728715
[TBL] [Abstract][Full Text] [Related]
40. The hyperproliferative endothelial cell phenotype in idiopathic pulmonary arterial hypertension.
Stevens T; Gillespie MN
Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L546-7. PubMed ID: 17601794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
